PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Liquid sublingual immunotherapy (SLIT) using a 3-tree extract (birch/alder/hazel) is used to treat patients with birch-family pollen respiratory allergy [PMID:40059026].
Corylus avellana is a source of inhalant allergies (pollen) and food allergies (ingestion) [PMID:25035912]. It is included in standard European skin prick test panels for inhalants [PMID:23369181].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 23369181 (2013) — The skin prick test - European standards. · Clinical and translational allergy
- 2.PMID: 30829410 (2019) — Birch pollen allergy in Europe. · Allergy
- 3.PMID: 11358108 (2001) — Final report on the safety assessment of Corylus Avellana (Hazel) Seed Oil, Corylus Americana (Hazel) Seed Oil, Corylus Avellana (Hazel) Seed Extract, Corylus Americana (Hazel) Seed Extract, Corylus Avellana (Hazel) Leaf Extract, Corylus Americana (Hazel) Leaf Extract, and Corylus Rostrata (Hazel) Leaf Extract. · International journal of toxicology
- 4.PMID: 35310662 (2022) — Corylus avellana L. Aroma Blueprint: Potent Odorants Signatures in the Volatilome of High Quality Hazelnuts. · Frontiers in plant science
- 5.PMID: 38005710